Records containing: X-linked Hypophosphatemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-17X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP)
-
CLINICAL_TRIALS study record update · 2025-11-14A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients With X-linked Hypophosphatemia
-
CLINICAL_TRIALS study record update · 2025-10-01Calcitriol Monotherapy for X-Linked Hypophosphatemia: Effects on Mineral Ions, Growth and Skeletal Parameters
-
CLINICAL_TRIALS study record update · 2025-04-13ATP (Adenosine Triphosphate) Concentration Measurement by Phosphorus-31 Spectroscopy in Phosphate Diabetes
-
CLINICAL_TRIALS study record update · 2025-03-05ClinicalTrials.gov study NCT03775187
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-06-17A Phase I, Double-blind, Randomized, Placebo-controlled, Single-dose, Dose-escalation Study of KRN23 in X-linked Hypophosphatemia
-
CLINICAL_TRIALS study record update · 2023-11-29Characterising Pain, Quality of Life, Body Composition, Arterial Stiffness, Muscle Function, Bone Density and Geometry in Adult Persons With Hereditary Hypophosphatemia and Healthy Controls
-
CLINICAL_TRIALS study record update · 2023-10-10Mid- and Forefoot Disorders in Adolescents and Adults With X-linked Hypophosphatemia
-
CLINICAL_TRIALS study record update · 2023-08-24Examining the Effect of Burosumab on Muscle Function Using MR Spectroscopy
-
CLINICAL_TRIALS study record update · 2023-05-03An Investigator-sponsored Phase 3b Open-label Study of Anti- FGF23 Antibody Burosumab (KRN23) in Adult Patients With Xlinked Hypophosphatemia (XLH) in GERmany - BurGER
-
CLINICAL_TRIALS study record update · 2022-08-05Interplay of FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
-
CLINICAL_TRIALS study record update · 2022-06-30Dental Implants in Patients With X-linked Hypophosphatemia
-
CLINICAL_TRIALS study record update · 2022-05-20A Phase 3b Open-label Study of the Anti-FGF23 Antibody, Burosumab (KRN23) in Adult Patients With X-linked Hypophosphatemia (XLH)
-
CLINICAL_TRIALS study record update · 2021-02-17An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
-
CLINICAL_TRIALS study record update · 2021-02-05A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With Open-Label Extension to Assess the Efficacy and Safety of KRN23 in Adults With X-linked Hypophosphatemia (XLH)
-
CLINICAL_TRIALS study record update · 2020-10-27X-linked Hypophosphatemia and Carbohydrate and Lipid Metabolism: a Role for FGF21?
-
CLINICAL_TRIALS study record update · 2020-10-26A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
-
CLINICAL_TRIALS study record update · 2020-06-0512-months of Treatment With Burosumab in Children and Adolescents With X-linked Hypophosphatemia: a Prospective Longitudinal Cohort Study
-
CLINICAL_TRIALS study record update · 2019-05-22A Randomized, Open-Label, Dose Finding, Phase 2 Study to Assess the Pharmacodynamics and Safety of the Anti-FGF23 Antibody, KRN23, in Pediatric Patients With X-linked Hypophosphatemia (XLH)
-
CLINICAL_TRIALS study record update · 2019-01-30Comparing the Effectiveness of High or Low Dose of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia
-
CLINICAL_TRIALS study record update · 2018-09-25An Open-Label, Single-Arm, Phase 3 Study to Evaluate the Effects of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)